{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:32:37Z","timestamp":1790127157766,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Scientific Research Projects Commission of Ankara University"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.eplepsyres.2019.03.009","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T13:32:41Z","timestamp":1552656761000},"page":"7-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Effects of levetiracetam and valproic acid treatment on liver function tests, plasma free carnitine and lipid peroxidation in childhood epilepsies"],"prefix":"10.1016","volume":"153","author":[{"given":"P\u0131nar","family":"Haznedar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem","family":"Do\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pelin","family":"Albayrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6k\u00e7en","family":"\u00d6z Tun\u00e7er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serap","family":"Teber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclhis","family":"Deda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Tuba","family":"Eminoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2019.03.009_bib0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pbb.2015.05.020","article-title":"Omega 3 polyunsaturated fatty acids enhance the protective effect of levetiracetam against seizures, cognitive impairment and hippocampal oxidative DNA damage in young kindled rats","volume":"135","author":"Abdel-Wahab","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"9","key":"10.1016\/j.eplepsyres.2019.03.009_bib0010","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/adc.2009.165902","article-title":"A systematic review of safety monitoring and drug toxicity in published randomised controlled trials of antiepileptic drugs in children over a 10-year period","volume":"95","author":"Anderson","year":"2010","journal-title":"Arch. Dis. Child."},{"issue":"3","key":"10.1016\/j.eplepsyres.2019.03.009_bib0015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1528-1157.1997.tb01128.x","article-title":"Quality of life of people with epilepsy: a European study","volume":"38","author":"Baker","year":"1997","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.eplepsyres.2019.03.009_bib0020","doi-asserted-by":"crossref","first-page":"e0175990","DOI":"10.1371\/journal.pone.0175990","article-title":"Reproductive toxicity after levetiracetam administration in male rats: evidence for role of hormonal status and oxidative stress","volume":"12","author":"Baysal","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.eplepsyres.2019.03.009_bib0025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0005-2728(98)00114-5","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"1366","author":"Beal","year":"1998","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Bioenerg."},{"issue":"2\u20133","key":"10.1016\/j.eplepsyres.2019.03.009_bib0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.eplepsyres.2008.08.008","article-title":"Levetiracetam in newly diagnosed late-onset post-stroke seizures: a prospective observational study","volume":"82","author":"Belcastro","year":"2008","journal-title":"Epilepsy Res."},{"issue":"1-3","key":"10.1016\/j.eplepsyres.2019.03.009_bib0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0378-4274(01)00415-5","article-title":"Neuroprotective role of l-carnitine in the 3-nitropropionic acid induced neurotoxicity","volume":"125","author":"Binienda","year":"2001","journal-title":"Toxicol. Lett."},{"issue":"2","key":"10.1016\/j.eplepsyres.2019.03.009_bib0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1684\/epd.2015.0736","article-title":"Incidence, prevalence and aetiology of seizures and epilepsy in children","volume":"17","author":"Camfield","year":"2015","journal-title":"Epileptic Disord."},{"issue":"4","key":"10.1016\/j.eplepsyres.2019.03.009_bib0045","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/phrs.1999.0603","article-title":"The effects of carbamazepine and valproic acid on the erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children","volume":"41","author":"Cengiz","year":"2000","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.eplepsyres.2019.03.009_bib0050","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/03602530600959433","article-title":"Oxidative stress as a mechanism of valproic acid-associated hepatotoxicity","volume":"38","author":"Chang","year":"2006","journal-title":"Drug Metab. Rev."},{"issue":"10","key":"10.1016\/j.eplepsyres.2019.03.009_bib0055","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1096\/fj.02-0752rev","article-title":"Oxidative DNA damage: mechanisms, mutation, and disease","volume":"17","author":"Cooke","year":"2003","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.eplepsyres.2019.03.009_bib0060","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1586\/ern.10.71","article-title":"Adverse effects of antiepileptic drugs: a brief overview of important issues","volume":"10","author":"Cramer","year":"2010","journal-title":"Expert Rev. Neurother."},{"issue":"2","key":"10.1016\/j.eplepsyres.2019.03.009_bib0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1043-6618(02)00080-4","article-title":"Methodology for urinary 8-hydroxy-2\u2032-deoxyguanosine analysis by HPLC with electrochemical detection","volume":"46","author":"De Martinis","year":"2002","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.eplepsyres.2019.03.009_bib0070","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.eplepsyres.2019.03.009_bib0075","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMcp0801738","article-title":"Clinical practice. Initial management of epilepsy","volume":"359","author":"French","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.eplepsyres.2019.03.009_bib0080","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1016\/S0021-9258(18)62884-4","article-title":"Quantitative aspects of the production of superoxide anion radical by milk xanthine oxidase","volume":"245","author":"Fridovich","year":"1970","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.eplepsyres.2019.03.009_bib0085","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0887-8994(02)00460-5","article-title":"Carnitine level in Chinese epileptic patients taking sodium valproate","volume":"28","author":"Fung","year":"2003","journal-title":"Pediatr. Neurol."},{"issue":"9","key":"10.1016\/j.eplepsyres.2019.03.009_bib0090","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.seizure.2014.06.004","article-title":"Behavioral side-effects of levetiracetam in children with epilepsy: a systematic review","volume":"23","author":"Halma","year":"2014","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.eplepsyres.2019.03.009_bib0095","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1212\/01.WNL.0000033622.27961.B6","article-title":"Practice parameter: treatment of the child with a first unprovoked seizure: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society","volume":"60","author":"Hirtz","year":"2003","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.eplepsyres.2019.03.009_bib0100","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1590\/S0004-282X1995000500001","article-title":"Hepatic enzymes\u2019 level during chronic use of anticonvulsant drugs","volume":"53","author":"Hoshino","year":"1995","journal-title":"Arq. Neuropsiquiatr."},{"issue":"1","key":"10.1016\/j.eplepsyres.2019.03.009_bib0105","doi-asserted-by":"crossref","DOI":"10.17826\/cutf.00658","article-title":"Levetirasetam ve Valproik asid: \u00c7ocuklarda Karaci\u011fer Fonksiyonlar\u0131 ve Amonyak D\u00fczeyleri \u00dczerine Etkileri","volume":"39","author":"\u0130ncecik","year":"2014","journal-title":"Cukurova Med. J. (\u00c7ukurova \u00dcniversitesi T\u0131p Fak\u00fcltesi Dergisi)"},{"issue":"6","key":"10.1016\/j.eplepsyres.2019.03.009_bib0110","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/ajcn\/80.6.1611","article-title":"Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism","volume":"80","author":"James","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"issue":"12","key":"10.1016\/j.eplepsyres.2019.03.009_bib0115","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.4088\/JCP.14r09179","article-title":"Oxidative stress and antioxidant parameters in patients with major depressive disorder compared to healthy controls before and after antidepressant treatment: results from a meta-analysis","volume":"76","author":"Jimenez-Fernandez","year":"2015","journal-title":"J. Clin. Psychiatry"},{"issue":"11","key":"10.1016\/j.eplepsyres.2019.03.009_bib0120","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1177\/1087054713510354","article-title":"Oxidative stress and ADHD: a meta-analysis","volume":"19","author":"Joseph","year":"2015","journal-title":"J. Atten. Disord."},{"issue":"3","key":"10.1016\/j.eplepsyres.2019.03.009_bib0125","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.yebeh.2008.04.025","article-title":"Levetiracetam monotherapy for late poststroke seizures in the elderly","volume":"13","author":"Kutlu","year":"2008","journal-title":"Epilepsy Behav."},{"issue":"10","key":"10.1016\/j.eplepsyres.2019.03.009_bib0130","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.lfs.2003.08.006","article-title":"Levetiracetam protects against kainic acid-induced toxicity","volume":"74","author":"Marini","year":"2004","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.eplepsyres.2019.03.009_bib0135","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM198507183130303","article-title":"Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures","volume":"313","author":"Mattson","year":"1985","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.eplepsyres.2019.03.009_bib0140","first-page":"CD001901","article-title":"Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane review","volume":"2012","author":"Mbizvo","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.eplepsyres.2019.03.009_bib0145","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.seizure.2012.09.003","article-title":"Oxidative stress in patients with epilepsy is independent of antiepileptic drugs","volume":"21","author":"Menon","year":"2012","journal-title":"Seizure"},{"issue":"5","key":"10.1016\/j.eplepsyres.2019.03.009_bib0150","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jpeds.2006.08.015","article-title":"Oxidative stress in children receiving valproic acid","volume":"149","author":"Michoulas","year":"2006","journal-title":"J. Pediatr."},{"issue":"15","key":"10.1016\/j.eplepsyres.2019.03.009_bib0155","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.clinbiochem.2013.06.012","article-title":"Adverse drug reactions induced by valproic acid","volume":"46","author":"Nanau","year":"2013","journal-title":"Clin. Biochem."},{"issue":"6","key":"10.1016\/j.eplepsyres.2019.03.009_bib0160","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1440-1746.2006.04231.x","article-title":"Oxidative stress in the development of liver cirrhosis: a comparison of two different experimental models","volume":"21","author":"Natarajan","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2019.03.009_bib0165","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.eplepsyres.2004.08.005","article-title":"Effect of pentylenetetrazol-induced epileptic seizure on thiol redox state in the mouse cerebral cortex","volume":"62","author":"Patsoukis","year":"2004","journal-title":"Epilepsy Res."},{"issue":"9","key":"10.1016\/j.eplepsyres.2019.03.009_bib0170","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1111\/epi.12326","article-title":"Results of phase II levetiracetam trial following acute head injury in children at risk for posttraumatic epilepsy","volume":"54","author":"Pearl","year":"2013","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.eplepsyres.2019.03.009_bib0175","doi-asserted-by":"crossref","first-page":"82","DOI":"10.14581\/jer.14017","article-title":"Valproic acid-induced hyperammonemic encephalopathy promoted by levetiracetam","volume":"4","author":"Roh","year":"2014","journal-title":"J. Epilepsy Res."},{"issue":"Suppl. 5","key":"10.1016\/j.eplepsyres.2019.03.009_bib0180","first-page":"1229","article-title":"Lipid peroxidation products and antioxidants in human disease","volume":"106","author":"Romero","year":"1998","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.eplepsyres.2019.03.009_bib0185","article-title":"Role of ketamine, levetiracetam and l-carnitine in aminophylline induced seizure in Wister rat model","author":"Roy","year":"2015","journal-title":"Am. J. Phytomed. Clin. Ther."},{"issue":"5","key":"10.1016\/j.eplepsyres.2019.03.009_bib0190","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1528-1157.1988.tb03757.x","article-title":"Fatal liver failure in 16 children with valproate therapy","volume":"29","author":"Scheffner","year":"1988","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.eplepsyres.2019.03.009_bib0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5698\/1535-7511-11.1.9","article-title":"Efficacy of new antiepileptic drugs","volume":"11","author":"Schmidt","year":"2011","journal-title":"Epilepsy Curr."},{"issue":"2-3","key":"10.1016\/j.eplepsyres.2019.03.009_bib0200","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tox.2005.10.004","article-title":"Valproic acid monotherapy induces DNA oxidative damage","volume":"217","author":"Schulpis","year":"2006","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.eplepsyres.2019.03.009_bib0205","doi-asserted-by":"crossref","DOI":"10.4172\/Neuropsychiatry.1000178","article-title":"Plasma ammonia levels in patients treated with valproic acid","volume":"7","author":"Tesen","year":"2017","journal-title":"Neuropsychiatry"},{"issue":"2","key":"10.1016\/j.eplepsyres.2019.03.009_bib0210","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1474-4422(15)00314-2","article-title":"Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug","volume":"15","author":"Tomson","year":"2016","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.eplepsyres.2019.03.009_bib0215","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1097\/MD.0000000000000066","article-title":"Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy","volume":"93","author":"Tseng","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.eplepsyres.2019.03.009_bib0220","first-page":"211","article-title":"Carnitine deficiency during valproic acid treatment","volume":"65","author":"Van Wouwe","year":"1994","journal-title":"Int. J. Vitam. Nutr. Res. (Internationale Zeitschrift fur Vitamin-und Ernahrungsforschung Journal international de vitaminologie et de nutrition)"},{"issue":"1","key":"10.1016\/j.eplepsyres.2019.03.009_bib0225","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s005990050060","article-title":"Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs","volume":"29","author":"Verrotti","year":"1999","journal-title":"Int. J. Clin. Lab. Res."},{"issue":"2\u20133","key":"10.1016\/j.eplepsyres.2019.03.009_bib0230","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.eplepsyres.2007.11.005","article-title":"Increased oxidative stress in epileptic children treated with valproic acid","volume":"78","author":"Verrotti","year":"2008","journal-title":"Epilepsy Res."},{"issue":"5","key":"10.1016\/j.eplepsyres.2019.03.009_bib0235","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s40263-015-0248-9","article-title":"Levetiracetam monotherapy in children with epilepsy: a systematic review","volume":"29","author":"Weijenberg","year":"2015","journal-title":"CNS Drugs"},{"issue":"8","key":"10.1016\/j.eplepsyres.2019.03.009_bib0240","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/epi.13057","article-title":"Summary of recommendations for the management of infantile seizures: task force report for the ILAE Commission of Pediatrics","volume":"56","author":"Wilmshurst","year":"2015","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.eplepsyres.2019.03.009_bib0245","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1515\/JBCPP.2000.11.1.73","article-title":"Erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children with valproate and carbamazepine monotherapy","volume":"11","author":"Yuksel","year":"2000","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2019.03.009_bib0250","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1651-2227.1995.tb13494.x","article-title":"Reduced carnitine and antiepileptic drugs: cause relationship or co-existence?","volume":"84","author":"Zelnik","year":"1995","journal-title":"Acta Paediatr."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121118306119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121118306119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:41:03Z","timestamp":1760276463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121118306119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":50,"alternative-id":["S0920121118306119"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2019.03.009","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of levetiracetam and valproic acid treatment on liver function tests, plasma free carnitine and lipid peroxidation in childhood epilepsies","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2019.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}